Atopic Dermatitis Leads the Pruritus Therapeutics Market With a 50.8% Revenue Share
Chronic itch is more than an annoyance. It disrupts sleep, affects mental well-being, and often signals a larger condition such as atopic dermatitis, kidney disease, or liver disorders. That burden is why pruritus therapeutics is an area of active investment in dermatology and immunology. Here is a look at where the market stands, what is driving it, and how it differs by region. Market Size...
0 Yorumlar 0 hisse senetleri 14 Views 0 önizleme
AC Mingle https://acmingle.com